Last updated: May 3, 2024
Sponsor: InnoCon Medical
Overall Status: Active - Recruiting
Phase
N/A
Condition
Urinary Incontinence
Gastrointestinal Diseases And Disorders
Rectal Disorders
Treatment
UCon-Bar
Clinical Study ID
NCT06091566
DK_FEAS_02
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participant is female
- Participant is ≥ 18 years of age.
- Participant is diagnosed with OAB or BD. OAB: Urinary urgency usually with one or more of the following: i. Urinary urgency incontinence (≥1 per/week). ii. Urinary frequency (≥8 voiding/daywithout polyuria). iii. Nocturia (≥2 voiding/night without nocturnal polyuria). BD: One or more of the following: i. Faecal urgency (≥3 urgencies pr. week) together with registration of urgency in St.Mark´s and a St. Mark´s score ≥9. ii. Faecal incontinence (urge/passive) (≥1 per/week).
- Participant is able to communicate, provide feedback, understand and followinstructions during the course of the investigation, including using the device athome.
Exclusion
Exclusion Criteria:
- Participant is medically unstable (acute illness or complication of a chroniccondition, apart from the OAB or BD, that might affect the participants´ participationin the investigation).
- Participant has an active infection in the genital area.
- Participant has an implanted pacemaker, implantable drug pump or other active medicaldevices (any medical device that uses electrical energy or other sources of power tomake it function).
- Participant is pregnant, nursing or planning a pregnancy (to be confirmed with anegative pregnancy test). Women of childbearing potential must maintain effectivecontraception during the clinical investigation.
- Participant is enrolled or planning to enrol in another conflicting clinicalinvestigation or was enrolled in an investigational drug trial or medical deviceinvestigation within four weeks of enrolment.
- Participant has neuropathy to a degree that is presumed to diminish the effect of theelectrical stimulation.
- Participant has a history of cancer in the pelvic region, are currently receivingcancer treatment, or has received radiation therapy in the pelvic region.
- Participant has addictive behaviour defined as the abuse of alcohol, cannabis,opioids, or other intoxicating drugs.
- Participant does not speak or understand Danish.
- The following contraception is considered effective: Intrauterine device,hormonal contraceptives such as birth control pills, implants, contraceptivepatch, vaginal ring, and contraceptive injection.
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: UCon-Bar
Phase:
Study Start date:
January 12, 2024
Estimated Completion Date:
January 01, 2026
Study Description
Connect with a study center
Aarhus University Hospital
Aarhus, 8200
DenmarkActive - Recruiting
Herlev Hospital
Herlev, 2730
DenmarkActive - Recruiting
Odense University Hospital
Odense, 5000
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.